Sp1293
EOSINOPHILIC ESOPHAGITIS: CLINICAL IMPLICATIONS OF DISEASE PROGRESSION
Date
May 9, 2023
Society: DDW
EoE is a chronic, type 2 inflammatory esophageal disease associated with dysphagia, regurgitation, and food impaction. Diagnostic delays result in disease progression, including stricture formation. Join us to explore beyond symptoms and uncover the essential role endoscopy and histology play in EoE diagnosis and management. Sponsored by Sanofi and Regeneron
EoE is a chronic, type 2 inflammatory esophageal disease associated with dysphagia, regurgitation, and food impaction. Diagnostic delays result in disease progression, including stricture formation. Join us to explore beyond symptoms and uncover the essential role endoscopy and histology play in EoE diagnosis and management. Sponsored by Sanofi and Regeneron
Presenter
Northwestern University - The Feinberg School of Medicine
Tracks
Related Products
Hirano Symposium on Eosinophilic Gastrointestinal Disorders
LIVE STREAM SESSION Despite advances in the understanding and treatment of eosinophilic esophagitis (EoE), there continue to be controversies in the management of both adult and pediatric patients, such as the role of routine allergy testing, need for surveillance endoscopy, and selection of initia…
LONGITUDINAL EFFECTS OF TREATMENT ON ESOPHAGEAL DYSMOTILITY IN EOSINOPHILIC ESOPHAGITIS
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
<i>THE SEVERITY OF REDUCED ESOPHAGEAL DISTENSIBILITY PARALLELS EOSINOPHILIC DISEASE DURATION</i>
Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
